Skip to Content

SOLID

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (SOLID-TIMI 52)

Patient Information

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).

More details at: http://clinicaltrials.gov/show/NCT01000727

Study Number
NCT01000727

Clinical Trial Categories

  • Secondary Prevention Trials